Chemed Corp
NYSE:CHE
Chemed Corp
Cash from Financing Activities
Chemed Corp
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chemed Corp
NYSE:CHE
|
Cash from Financing Activities
-$31.8m
|
CAGR 3-Years
51%
|
CAGR 5-Years
30%
|
CAGR 10-Years
13%
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$575.3m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-2%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
-$1.3B
|
CAGR 3-Years
55%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
0%
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$6.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-15%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is Chemed Corp's Cash from Financing Activities?
Cash from Financing Activities
-31.8m
USD
Based on the financial report for Mar 31, 2024, Chemed Corp's Cash from Financing Activities amounts to -31.8m USD.
What is Chemed Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
13%
Over the last year, the Cash from Financing Activities growth was 81%. The average annual Cash from Financing Activities growth rates for Chemed Corp have been 51% over the past three years , 30% over the past five years , and 13% over the past ten years .